Estimate of Opportunistic Prostate Specific Antigen Testing in the Finnish Randomized Study of Screening for Prostate Cancer-Reference-Cited by-同舟云学术

Estimate of Opportunistic Prostate Specific Antigen Testing in the Finnish Randomized Study of Screening for Prostate Cancer

Published:2017-07 Issue:1 Volume:198 Page:50-57
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Kilpeläinen Tuomas P.¹,Pogodin-Hannolainen Dimitri²,Kemppainen Kimmo³,Talala Kirsi⁴,Raitanen Jani³⁵,Taari Kimmo¹,Kujala Paula⁶,Tammela Teuvo L.J.⁷⁸,Auvinen Anssi³

Affiliation:

1. Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

2. Department of Urology, Kanta-Häme Central Hospital, Hämeenlinna, Finland

3. School of Health Sciences, University of Tampere, Tampere, Finland

4. Finnish Cancer Registry, Helsinki, Finland

5. UKK Institute for Health Promotion Research, Tampere, Finland

6. Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland

7. Department of Urology, University of Tampere, Tampere University Hospital, Tampere, Finland

8. Department of Urology, Tampere University Hospital, Tampere, Finland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference26 articles.

1. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;Schröder;Lancet,2014

2. Overdiagnosis and overtreatment of prostate cancer;Loeb;Eur Urol,2014

4. Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data;Heijnsdijk;J Natl Cancer Inst,2014

5. Screening for prostate cancer;Ilic;Cochrane Database Syst Rev,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review;BJUI Compass;2024-02-09

2. Prostate Specific Antigen and Biopsy Contamination in the Göteborg-1 Randomized, Population-Based, Prostate Cancer Screening Trial;Journal of Urology;2022-11

3. Periodic trends in geographical variation of prostate cancer incidence and mortality in Finland between 1985 and 2019;Acta Oncologica;2022-08-25

4. Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial;Journal of Urology;2022-08

5. Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study;BJU International;2022-01-08